Histological Remission

Histological Remission is a clinical outcome criterion in autoimmune liver disease treatment characterized by the absence of active inflammatory and necroinflammatory lesions in liver tissue on histopathological examination, distinguishing it from biochemical or serological markers of disease activity.

645

Publications

38.8K

Citations

4.1K

Authors

1.3K

Institutions

Publications per year

2017–2026

174

Authors

4.1K

  1. SD
    Silvio Danese

    Humanitas University, Italy

    11 publications · 536 citations

    11

    h-index

  2. AJ
    Albert J. Czaja

    Mayo Clinic, United States

    9 publications · 1.1K citations

    9

    h-index

  3. SG
    Subrata Ghosh

    University of Calgary, Canada

    9 publications · 699 citations

    9

    h-index

  4. AW
    Ansgar W. Lohse

    Universität Hamburg, Germany

    9 publications · 1.1K citations

    9

    h-index

  5. LP
    Laurent Peyrin‐Biroulet

    Inserm, France

    9 publications · 458 citations

    9

    h-index

1–5 of 4.1K

Venues

  1. Journal of Crohn s and Colitis

    JCC · 33 publications · 1.7K citations

    24

    h-index

  2. PubMed

    Repository · 56 publications · 1.5K citations

    23

    h-index

  3. Alimentary Pharmacology & Therapeutics

    25 publications · 2.4K citations

    22

    h-index

  4. Hepatology

    20 publications · 5K citations

    19

    h-index

  5. Gut

    21 publications · 2.4K citations

    18

    h-index

1–5